News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 73–108
- Matches
- 2992
- Sources here
- 18
- Companies here
- 25
Active search
2992 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
LifeStance Health Group (NASDAQ:LFST) Given New $13.00 Price Target at JPMorgan Chase & Co.
JPMorgan Chase & Co. has raised its price target for LifeStance Health Group (NASDAQ:LFST) to $13.00 from $9.00, while maintaining a "neutral" rating. This new target implies a potential upside of 2.48% from the stock's previous close. The company recently reported strong quarterly earnings, …
Is EW Stock Worth Buying as Growth Clashes With a Premium Valuation?
Edwards Lifesciences Corporation EW is entering the second half of 2026 with faster structural heart growth and better operating leverage. Second-quarter revenues rose 13.6% to $1.74 billion, while adjusted earnings increased 16.4% to 78 cents per share. The question is whether that momentum warrants …
What Are Wall Street Analysts' Target Price for Globe Life Stock?
Globe Life Inc. (GL) has outperformed the broader market, with its stock up 30.6% over the past 52 weeks and 29.4% YTD. Despite beating Q2 2026 earnings estimates, the stock dropped due to weak sales trends and underwriting performance. Analysts maintain a "Moderate Buy" …
Sun Life Financial Inc. stock rises Friday, outperforms market
Sun Life Financial Inc. (SLF) stock rose 0.13% to C$112.88 on Friday, outperforming the Canadian market as the S&P/TSX Composite Index (GSPTSE) fell 0.08%. The company's shares closed 5.1% below its 52-week high of C$118.99, achieved on July 28th.
Liftoff Mobile, Inc. (LFTO) Q2 2026 Earnings Report - Results, Call & Slides
Liftoff Mobile, Inc. (LFTO) reported strong Q2 2026 results with significant revenue and operating profit increases, but a net loss of $4.2 million. Following the earnings release, the stock declined by 3.7%. Insider trading showed one significant purchase, and numerous institutional investors increased their …
HC Wainwright Analysts Boost Earnings Estimates for LifeMD
HC Wainwright analysts have increased their Q4 2027 earnings per share forecast for LifeMD to $0.17 from $0.15, while maintaining a "Buy" rating and a $9 price target. Despite this, analyst sentiment remains mixed with a "Moderate Buy" consensus rating but several recent downgrades. …
Cleveland-Cliffs wants to use green energy grant to preserve coal-burning technology
Cleveland-Cliffs plans to redirect a $500 million federal grant, originally intended to cut greenhouse gas emissions by replacing a coal-burning blast furnace at its Middletown steel plant, to instead preserve and optimize the existing coal-burning technology. The company CEO cited a lack of available …
Achieve Life Sciences, Inc. (NASDAQ:ACHV): Is Breakeven Near?
Achieve Life Sciences, Inc. (NASDAQ:ACHV) is a late-stage pharmaceutical company developing cytisinicline for nicotine independence. Despite widening losses to US$114m, analysts project the company to reach breakeven by 2028, with an anticipated 69% year-on-year growth. The company currently has negative equity on its balance …
MetLife (MET) details $13.1M in Form 13F holdings in combination report
MetLife Inc. (MET) has filed a Form 13F Combination Report detailing its equity holdings. The report summarizes 6 portfolio entries with an aggregate reported value of $13,089,220, representing Section 13(f) securities managed by its investment subsidiaries. MetLife clarifies that it disclaims direct investment discretion, …
Assenagon Asset Management S.A. Makes New Investment in California Water Service Group $CWT
Assenagon Asset Management S.A. has initiated a new investment in California Water Service Group (NYSE:CWT) during the second quarter, acquiring 42,371 shares valued at approximately $2.06 million. This investment contributes to institutional investors and hedge funds collectively owning 82.78% of the company. The utilities …
Assenagon Asset Management S.A. Reduces Position in Integra LifeSciences Holdings Corporation $IART
Assenagon Asset Management S.A. significantly reduced its stake in Integra LifeSciences Holdings Corporation by 66.3% in the second quarter of 2026, selling over 276,000 shares. Despite this, other institutional investors like Rubric Capital Management LP and Paradigm Capital Management Inc. NY increased their holdings. …
Why SELLAS (SLS) Posted a Wider Net Loss but a Narrower Per-Share Loss This Quarter
SELLAS Life Sciences Group (SLS) reported a wider net loss in Q2 2026 but a narrower loss per share, driven by increasing expenses related to late-stage oncology programs. The company's investment narrative continues to revolve around the success of its Phase 3 REGAL trial …
LifeMD, Inc. (NASDAQ:LFMD) Given Consensus Recommendation of "Moderate Buy" by Brokerages
LifeMD, Inc. (NASDAQ:LFMD) has received a "Moderate Buy" consensus rating from ten brokerages, with an average 12-month price target of $7.57. Despite this, the company reported a slight miss on quarterly earnings and revenue expectations, posting a loss of $0.16 per share and $47.28 …